News GSK's Luke Miels demands new focus, and cost cuts Further details have emerged about GlaxoSmithKline’s attempts to reinvigorate its business under new CEO Emma Walmsley.
Views & Analysis Improving oncology KOL engagement Combining technology with human insights is a powerful tool in identifying and engaging effectively with oncology experts.
News Roche's Tecentriq halts disease in squamous lung cancer Roche’s cancer immunotherapy Tecentriq has produced strong results which could give it the lead in a key lung cancer indication.
News Mundipharma to market Herceptin biosimilar in key EU markets Mundipharma's third biosimilar tie-up with Celltrion
Debates & Insight Sponsored Standing on the cusp of something great: How real-world data... REAL-WORLD EVIDENCE IN ONCOLOGY: Towards Innovative and Affordable Patient Care
News Adaptimmune and GSK’s novel T-cell therapy works in solid tu... Adaptimmune has more good news from its SPEAR T-cell therapy, yesterday unveiling encouraging early results in four patients with myxoid/round cell liposarcoma (MRCLS).
News EU clears first drug therapy for rare disease cALD Neuraxpharm and Minoryx' Nezglyal has become the first approved drug therapy in the EU for rare neurodegenerative disease cALD.
Digital Sponsored Discover a new era of healthcare panel engagement: Grounded ... A new webinar from Konovo will address some of the critical topics impacting today’s healthcare market research industry.
